Concise review: Adipose-derived stromal vascular fraction cells and platelet-rich plasma: Basic and clinical implications for tissue engineering therapies in regenerative surgery

Stem Cells Translational Medicine

Volumn 1, Issue 3, 2012, Pages 230-236

  Gentile, Pietro ^a   Orlandi, Augusto ^a   Scioli, Maria Giovanna ^a   Di Pasquali, Camilla ^a   Bocchini, Ilaria ^a   Valerio, Cervelli ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Adipose; Adipose stem cells; Stromal cells; Tissue specific stem cells

Indexed keywords

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL THERAPY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MORBIDITY; MUSCLE CELL; OSTEOBLAST; PLASTIC SURGERY; REGENERATIVE MEDICINE; REVIEW; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; TISSUE REGENERATION; BIOLOGICAL THERAPY; CYTOLOGY; PHYSIOLOGY; STROMA CELL;

ADIPOSE TISSUE; CELL DIFFERENTIATION; HUMANS; PLATELET-RICH PLASMA; REGENERATIVE MEDICINE; STROMAL CELLS; SURGERY, PLASTIC; TISSUE ENGINEERING; TISSUE THERAPY;

EID: 84872110977     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2011-0054     Document Type: Review

References (63)

1. Katz AJ, Tholpady A, Tholpady SS et al. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hA-DAS) cells. STEM CELLS 2005;23:412-423.
2. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001; 7:211-228.
3. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
4. TM system. Cytotherapy 2008;10:417-426.
5. Corselli M, Chen CW, Sun B et al. The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev 2011 [Epub ahead of print].
6. Schipper BM, Marra KG, Zhang W et al. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg 2008;60:538-544.
7. Levi B, James AW, Glotzbach JP et al. Depot-specific variation in the osteogenic and adipogenic potential of human adipose-derived stromal cells. Plast Reconstr Surg 2010; 126:822-834.
8. Xu Y, Malladi P, Wagner DR et al. Adiposederived mesenchymal cells as a potential cell source for skeletal regeneration. Curr Opin Mol Ther 2005;7:300-305.
9. Aksu AE, Rubin JP, Dudas JR et al. Role of gender and anatomical region on induction of osteogenic differentiation of human adiposederived stem cells. Ann Plast Surg 2008;60: 306-322.
10. De Ugarte DA, Morizono K, Elbarbary A et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003;174:101-109.
11. Jeon ES, Song HY, Kim MR et al. Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK. J Lipid Res 2006;47:653-664.
12. Kang YJ, Jeon ES, Song HY et al. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 2005;95:1135-1145.
13. Song HY, Jeon ES, Jung JS et al. Oncostatin M induces proliferation of human adipose tissue-derived mesenchymal stem cells. Int J Biochem Cell Biol 2005;37:2357-2365.
14. Zaragosi LE, Ailhaud G, Dani C. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. STEM CELLS 2006;24: 2412-2419.
15. Jun ES, Lee TH, Cho HH et al. Expression of telomerase extends longevity and enhances differentiation in human adipose tissue-derived stromal cells. Cell Physiol Biochem 2004; 14:261-268.
16. Wang M, Crisostomo P, Herring C et al. Human progenitor cells from bone marrow or adipose tissue produce VEGF, Hgf, and IGF-1 in response to Tnf by a p38 mitogen activated protein kinase dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006;291: R880-R884.
17. Yu G, Floyd E, Wu X et al. Isolation of human adipose-derived stem cells from lipoaspirates. Methods Mol Biol 2011;702: 17-27.
18. Cervelli V, Gentile P, De Angelis B et al. Application of enhanced stromal vascular fraction and fat grafting mixed with PRP in posttraumatic lower extremity ulcers. Stem Cell Res 2011;6:103-111.
19. Rigotti G, Marchi A, Galie M et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 2007;119: 1409-1422.
20. Yoshimura K, Sato K, Aoi N et al. Cellassisted lipotransfer for cosmetic breast augmentation: Supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 2008; 32:48-55.
21. Lendeckel S, Jödicke A, Christophis P et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: Case report. J Craniomaxillofac Surg 2004;32:370-373.
22. García-Olmo D, García-Arranz M, García LG et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005;48:1416-1423.
23. Rosen ED. The molecular control of adipogenesis, with special reference to lymphatic pathology. Ann NY Acad Sci 2002;979:143-158. discussion 188-196.
24. Schäffler A, Muller-Ladner U, Scholmerich J et al. Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 2006;27:449-467.
25. Lane MD, Tang QQ. From multipotent stem cell to adipocyte. Birth Defects Res A Clin Mol Teratol 2005;73:476-477.
26. Chargé SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004;84:209-238.
27. Brand-Saberi B. Genetic and epigenetic control of skeletal muscle development. Ann Anat 2005;187:199-207.
28. Tajbakhsh S. Skeletal muscle stem and progenitor cells: Reconciling genetics and lineage. Exp Cell Res 2005;306:364-372.
29. Otto WR, Rao J. Tomorrow's skeleton staff: Mesenchymal stem cells and the repair of bone and cartilage. Cell Prolif 2004;37:97-110.
30. Dani C. Embryonic stem cell-derived adipogenesis. Cells Tissues Organs 1999;165: 173-180.
31. Hong JH, Hwang ES, McManus MT et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005; 309:1074-1078.
32. Hong JH, Yaffe MB. TAZ: A beta-cateninlike molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 2006;5: 176-179.
33. Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg 1997;24:347.
34. Cho HH, Shin KK, Kim YJ et al. NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol 2010;223:168-177.
35. Cervelli V, Gentile P, Scioli MG et al. Application of platelet-rich plasma to fat grafting during plastic surgical procedures: Clinical and in vitro evaluation. Tissue Eng Part C 2009;15: 625-634.
36. Anitua E, Sánchez M, Nurden AT et al. Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A 2006;77: 285-293.
37. Kevy SV, Jacobson MS. Comparison of methods for point of care preparation of autologous platelet gel. J Extra Corpor Technol 2004;36:28-35.
38. Siebrecht MA, De Rooij PP, Arm DM et al. Platelet concentrate increases bone ingrowth into porous hydroxyapatite. Orthopedics 2002; 25:169-172.
39. Waters JH., Roberts KC. Database review of possible factors influencing point-of-care platelet gel manufacture. J Extra Corpor Technol 2004;36:250.
40. Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001;107:229.
41. Marlovits S, Mousavi M, Gabler C et al. A new simplified technique for producing platelet-rich plasma: A short technical note. Eur Spine J 2004;13(suppl 1):S102-S106.
42. Lozada JL, Caplanis N, Proussaefs P et al. Platelet-rich plasma application in sinus graft surgery: Part I. Background and processing techniques. J Oral Implantol 2001;27:38.
43. Hood AG, Arm DM. Topical application of autogenous tissue growth factors for augmentation of structural bone graft fusion. Paper presented at: American Society of Extra-Corporeal Technology 11th Annual Symposium on New Advances in Blood Management, April 20-23, 2004; Las Vegas, NV.
44. Mazzucco L, Balbo V, Cattana E et al. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 2009;97:110-118.
45. Cervelli V, Gentile P, Grimaldi M. Regenerative surgery: Use of fat grafting combined with platelet-rich plasma for chronic lower-extremity ulcers. Aesthetic Plast Surg 2009;33: 340-345.
46. Cervelli V, Gentile P, Casciani CU. Use of platelet gel in chronic lower extremity ulcers. Plast Reconstr Surg 2009;123:122e-123e.
47. Cervelli V, De Angelis B, Lucarini L et al. Tissue regeneration in loss of substance on the lower limbs through use of platelet-rich plasma, stem cells from adipose tissue, and hyaluronic acid. Adv Skin Wound Care 2010;23: 262-272.
48. Crovetti G, Martinelli G, Issi M et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 2004;30:145-151.
49. McAleer JP, Kaplan E, Persich G. Efficacy of concentrated autologous platelet-derived growth factors in chronic lower extremity wounds. J Am Podiatr Med Assoc 2006;96: 482-488.
50. Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft tissue injuries (review). Acta Dermatovenerol Alp Panonica Adriat 2007;16:156-165.
51. Kazakos K, Lyras DN, Verettas D et al. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury 2009; 40:801-805.
52. Powell DM, Chang E, Farrior EH. Recovery from deep-plane rhytidectomy following unilateral wound treatment with autologous platelet gel: A pilot study. Arch Facial Plast Surg 2001;3:245-250.
53. Man D, Plosker H, Winland-Brown JE. The use of autologous platelet rich plasma (platelet gel) and autologous platelet poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001;107:229-237.
54. Guerrerosantos J. Evolution of technique: Face and neck lifting and fat injections. Clin Plast Surg 2008;35:663-676.
55. Guerrerosantos J, Guerrerosantos F, Orozco J. Classification and treatment of facial tissue atrophy in Parry-Romberg disease. Aesthetic Plast Surg 2007;31:424-434.
56. Cervelli V, Gentile P. Use of cell fat mixed with platelet gel in progressive hemifacial atrophy. Aesthetic Plast Surg 2009;33:22-27.
57. Grimaldi M, Gentile P, Labardi L et al. Lipostructure technique in Romberg syndrome. J Craniofac Surg 2008;19:1089-1091.
58. Coleman SR. Long-term survival of fat transplants: Controlled demonstrations. Aesthetic Plast Surg 1995;19:421-425.
59. Azzena B, Mazzoleni F, Abatangelo G et al. Autologous platelet-rich plasma as an adipocyte in vivo delivery system: Case report. Aesthetic Plast Surg 2008;32:155-158.discussion 159-161.
60. Matsumoto D, Sato K, Gonda K et al. Cellassisted lipotransfer: Supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng 2006;12: 3375-3382.
61. Alvarez PD, García-Arranz M, Georgiev-Hristov T et al. A new bronchoscopic treatment of tracheomediastinal fistula using autologous adipose-derived stem cells. Thorax 2008;63: 374-376.
62. Yañez R, Lamana ML, García-Castro J et al. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. STEM CELLS 2006;24:2582-2591.
63. Fang B, Song Y, Liao L et al. Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant Proc 2007;39:3358-3362.